Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy.

Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy.
复制标题

DOI:
10.1007/s00705-016-2855-2
复制
发表时间:
2016-07
影响因子:
2.7
通讯作者:
Diah S
Diah S
中科院分区:
医学4区
文献类型:
--
作者:
Idris F;Muharram SH;Diah S

文献摘要

参考文献

被引文献

相似文献

登革病毒是一种属于黄病毒属的RNA病毒,每年感染5000万人,其中约50万 - 100万例感染会导致登革出血热或登革休克综合征。由于没有获得许可的疫苗或特定的抗病毒治疗方法来预防登革感染,登革热在亚热带和热带地区被视为一个主要的公共卫生问题。该病毒与其他有包膜的病毒一样,利用宿主的细胞酶来合成其结构蛋白(C、E和prM/M)和非结构蛋白(NS1 - 5),随后对这些蛋白进行糖基化以产生完整且有功能的糖蛋白。已知结构糖蛋白,特别是E蛋白,通过病毒蛋白的N - 糖基化位点与宿主的碳水化合物受体相互作用,从而介导病毒对细胞的入侵。本文综述重点关注登革糖蛋白在感染过程中的作用以及病毒对宿主聚糖的利用,特别是宿主受体与碳水化合物部分之间的相互作用。我们还讨论了针对这些过程和相互作用的抗病毒疗法的最新进展,特别关注使用从植物中提取的碳水化合物结合剂(通常称为凝集素)来抑制感染的进展。
Dengue virus, an RNA virus belonging to the genus Flavivirus, affects 50 million individuals annually, and approximately 500,000–1,000,000 of these infections lead to dengue hemorrhagic fever or dengue shock syndrome. With no licensed vaccine or specific antiviral treatments available to prevent dengue infection, dengue is considered a major public health problem in subtropical and tropical regions. The virus, like other enveloped viruses, uses the host’s cellular enzymes to synthesize its structural (C, E, and prM/M) and nonstructural proteins (NS1–5) and, subsequently, to glycosylate these proteins to produce complete and functional glycoproteins. The structural glycoproteins, specifically the E protein, are known to interact with the host’s carbohydrate receptors through the viral proteins’ N-glycosylation sites and thus mediate the viral invasion of cells. This review focuses on the involvement of dengue glycoproteins in the course of infection and the virus’ exploitation of the host’s glycans, especially the interactions between host receptors and carbohydrate moieties. We also discuss the recent developments in antiviral therapies that target these processes and interactions, focusing specifically on the use of carbohydrate-binding agents derived from plants, commonly known as lectins, to inhibit the progression of infection.
DOI: 10.1111/j.1745-7270.2006.00140.x
发表时间: 2006-02-01
影响因子: 3.7
作者:
An, J;Liu, JZ;Bao, JK
通讯作者: Bao, JK
DOI: 10.1128/jvi.79.13.8303-8315.2005
发表时间: 2005-07-01
影响因子: 5.4
作者:
Chiu, WW;Kinney, RM;Dreher, TW
通讯作者: Dreher, TW
DOI: 10.1128/jvi.74.1.564-572.2000
发表时间: 2000-01-01
影响因子: 5.4
作者:
Courageot, MP;Frenkiel, MP;Desprès, P
通讯作者: Desprès, P
DOI: 10.1371/journal.ppat.0030183
发表时间: 2007-11
期刊: PLoS pathogens
影响因子: 6.7
作者:
Avirutnan P;Zhang L;Punyadee N;Manuyakorn A;Puttikhunt C;Kasinrerk W;Malasit P;Atkinson JP;Diamond MS
通讯作者: Diamond MS
DOI: 10.1038/nature07013
发表时间: 2008-05-29
期刊: NATURE
影响因子: 64.8
作者:
Chen, Szu-Ting;Lin, Yi-Ling;Hsieh, Shie-Liang
通讯作者: Hsieh, Shie-Liang